Promoting physiologic-physical adaptation in chronic obstructive pulmonary disease: pharmacotherapeutic evidence-based research and guidelines.
Guidelines from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and evidence-based research include advanced pharmacologic care for patients with chronic obstructive pulmonary disease (COPD). Although clinical trials of medications have not supported evidence that long-term decline in pulmonary function can be prevented, pharmacologic agents can reduce symptoms and prevent complications. High-quality home care services may improve quality of life and prevent hospital admissions because of acute exacerbations.
McAllister
Margaret
M
UMass Boston College of Nursing and Health Sciences, 100 Morrissey Boulevard, Boston, MA 02125, USA. margaret.mcallister@umb.edu
D000222:Adaptation, Physiological; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000402:Airway Obstruction / Q000175:diagnosis / Q000209:etiology / Q000451:nursing; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D019317:Evidence-Based Medicine / Q000592:standards*; D005100:Expectorants / Q000627:therapeutic use; D006699:Home Care Services / Q000592:standards*; D006801:Humans; D009730:Nursing Assessment / Q000379:methods; D010102:Oxygen Inhalation Therapy / Q000451:nursing; D017410:Practice Guidelines as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000145:classification / Q000150:complications / Q000188:drug therapy* / Q000451:nursing / Q000503:physiopathology*; D018570:Risk Assessment / Q000379:methods; D013806:Theophylline / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018680:Cholinergic Antagonists; D005100:Expectorants; D013806:Theophylline